EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Frontiers In Antiinfective Drug Discovery Volume 6 Attaurrehman M Iqbal Chaudhary

Name: Frontiers In Antiinfective Drug Discovery Volume 6 Attaurrehman M Iqbal Chaudhary
SKU: BELL-47701930
Price: 31.00 USD
Availability: InStock
Rating: 4.4 (72 reviews)

SKU: BELL-47701930

$ 31.00 ~~$ 45.00~~ (-31%)

4.4

72 reviews

Frontiers In Antiinfective Drug Discovery Volume 6 Attaurrehman M Iqbal Chaudhary instant download after payment.

Publisher: Bentham Science Publishers Ltd.

File Extension: PDF

File size: 20.97 MB

Author: Atta-ur-Rehman & M. Iqbal Chaudhary

ISBN: 9781681084800, 9781681084794, 1681084805, 1681084791

Language: English

Year: 2017

Product desciption

Frontiers In Antiinfective Drug Discovery Volume 6 Attaurrehman M Iqbal Chaudhary by Atta-ur-rehman & M. Iqbal Chaudhary 9781681084800, 9781681084794, 1681084805, 1681084791 instant download after payment.

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.